BioCentury
ARTICLE | Politics & Policy

HHS considering all options for drug prices

February 12, 2016 2:27 AM UTC

HHS Secretary Sylvia Burwell told members of the U.S. House Ways and Means Committee that HHS is "continuing to try and pursue every administrative option" to combat high drug prices, and is considering issuing guidelines on when NIH may exercise its march-in authority. The comment came in response to a question from Rep. Lloyd Doggett (D-Texas) during a committee hearing on Wednesday to discuss President Obama's FY17 budget request for HHS. ...